drugset / Trial / NCT01639729

Effect of Delivery Route on PK of Sufentanil NanoTab

NCT01639729

Phase 1 Completed 25 enrolled Talphera, Inc
RandomizedCrossoverOpen-labelBasic science

Summary

Determine whether the amount of drug absorbed is different if the tablet is placed under the tongue, placed between the cheek and gum, or swallowed.

Timeline

Start
2012-07
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Sufentanil Other / unclassified 15 ug Intravenous

Indications

No indication recorded.